Keyphrases
Cannabidiol
100%
Chromosome Doubling
100%
Placebo-controlled Trial
100%
Neuropathic Pain
100%
Cannabis-based Medicine
100%
Spasticity
100%
Colorectal Cancer
100%
Circulating Tumor DNA (ctDNA)
100%
Tetrahydrocannabinol
88%
Spinal Cord Injury
44%
Multiple Sclerosis
44%
DNA Detection
41%
Tumor
33%
Placebo
22%
Pain Intensity
22%
Colorectal Cancer Patients
16%
Tumor Cells
16%
Early Disease
16%
EudraCT
11%
Maximum Tolerated Dose
11%
Quality of Life
11%
Treatment Duration
11%
Four-arm
11%
Parallel Trials
11%
Numerical Rating Scale
11%
COVID-19 Challenges
11%
Δ9-tetrahydrocannabinol (Δ9-THC)
11%
Patient Global Impression of Change
11%
No Significant Difference
11%
Denmark
11%
Placebo Treatment
11%
Central Neuropathic Pain
11%
Active Treatment
11%
Life Changes
11%
Recruitment Challenges
11%
EU Clinical Trials Register
11%
Tumor Size
8%
Residual Disease
8%
Copy number
8%
Tumor-informed
8%
UICC Stage
8%
Sequence Data
8%
DNA Analysis
8%
Advanced Disease
8%
Plasma Samples
8%
Whole Exome Sequencing
8%
Practice Changing
8%
Disease Stage
8%
Tumor Characteristics
8%
Newly Diagnosed
8%
Medicine and Dentistry
Cannabis
100%
Spasticity
100%
Neuropathic Pain
100%
Circulating Tumor DNA
100%
Medicine
100%
Placebo
100%
Colorectal Cancer
100%
Nabiximols
71%
Neoplasm
58%
Tetrahydrocannabinol
57%
Cannabidiol
57%
Spinal Cord Injury
57%
Multiple Sclerosis
57%
Disease
25%
Tumor Cell
16%
Arm
14%
Dronabinol
14%
Treatment Duration
14%
Numeric Rating Scale
14%
Effects of Cannabis
14%
COVID-19
14%
Quality of Life
14%
Clinical Trial
14%
Minimal Residual Disease
8%
Biological Marker
8%
Malignant Neoplasm
8%
DNA Determination
8%
Exome Sequencing
8%
Whole Cell
8%
Pharmacology, Toxicology and Pharmaceutical Science
Neuropathic Pain
100%
Placebo
100%
Spasticity
100%
Cannabis
100%
Nabiximols
71%
Cannabidiol
57%
Multiple Sclerosis
57%
Tetrahydrocannabinol
57%
Spinal Cord Injury
57%
Dronabinol
14%
Clinical Trial
14%